This study was designed to clarify the clinical significance of plasma vasoactive substances including atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) as a survival predictor in chronic hemodialysis (HD) patients. Cardiothoracic ratio (CTR) and blood pressure were measured and blood samples were collected before the HD session for the measurements of ANP, BNP, plasma renin activity (PRA) and noradrenalin (PNA) in 52 HD patients. During 13-year follow-up period 41 patients died; 18 of either sudden death or cardiac death, 7 strokes, 8 infections, 5 other diseases, 2 accidents, and 1 suicide. Patients were divided into two groups using the median of their age and clinical and laboratory variables. Kaplan-Meier (KM) survival analysis demonstrated that the groups showing older age, lower serum albumin level and higher plasma BNP concentration had significantly lower survival rates as compared with each counterpart (p<0.001, p=0.008, p<0.001, respectively). Univariate and multivariate Cox proportional hazard regression analysis was used to assess the potential association of patient age, and clinical and laboratory variables. Univariate Cox hazard analysis showed that age, CTR, serum albumin level and plasma BNP concentration had a significant relationship with overall mortality (p<0.001, p=0, 010, p<0.001, p=0.011, respectively). However, stepwise multivariate analysis demonstrated that there was a significant relationship with overall mortality for patient age (p<0.001), and serum albumin level (p=0.020). The relationship with overall mortality was not significant for plasma BNP concentration (p=0.062) or CTR (p=0.816). These results demonstrated that age and serum albumin level were independent risk factors for long-term survival and that the plasma BNP concentration was an important risk factor next to age and serum albumin level, though it was not independent. Predialysis plasma ANP level was not significantly associated with overall mortality.
View full abstract